Summary. The proportion of total plasma immunereactive insulin comprising the proinsulin-like component was determined in 5 diabetic subjects manifesting fasting hyperglycemia, severe g]ucose intolerance, and insulinopenia, and also in one insulinopenie patient both before and after removal of a phaeoehromoeytoma. The proinsulin-like component comprised a mean of 37% (range 30--50%) of the total immunoreaetive insulin in the basal state, 27% (range 20--32%) at 15 min, and 32% (range 23 --50 %) 120 rain after i 00 g of oral glucose. These values are significantly higher than in normal subjects or patients with hyperinsulinemic responses (excepting patients with insulinoma). Our studies suggest that diseases that affect the B-cell's ability to store insulin or prevent the secretory granule of the B-cell from undergoing full maturation will be associated with an increased secretion from immature granules, that contain a higher percentage of proinsulin-like components. The proportion of the total immunoreaetive insulin comprising the proinsulin-like component is, therefore, a reflection of the integrity of the B-cell granule.
Following the description of proinsulin by Steiner and Oyer [2] , we demonstrated that plasma immunoreactive insulin (IRI) comprises at least two discrete components [3] . The plasma "big" insulin component has subsequently been shown to comprise several factors which are all related to pancreatic proinsulin and is referred to as the proinsulin-like component (PLC), while the plasma "little" insulin component has been found to be indistinguishable from pancreatic insulin [4--10] .
Although the role of proinsulin in the biosynthesis of insulin is clear, the significance of the circulating PLC remains unclear. In our initial study we reported that the "big", or PLC, from a normal subject comprised about 20% of the total plasma IRI [3] . Subsequent reports of our own, [11, 12] as well as reports from a number of other laboratories [10, 13, 14] using gel filtration techniques, have confirmed that the PLC comprises an average of about 20% (range 10--30%) of the total basal IRI in normal subjects. Aside from patients with insulinomas, the other major groups of patients that have been studied are hyperinsulinemie, usually insulin resistant patients, e.g. obesity with and without glucose intolerance, acromegaly, and Cushing's disease. While these patients have a higher absolute concentration of the PLC, commensurate with their high total insulin concentration, the PLC comprises approximately the same percentage of the total IRI as in normal subjects [10, 12, 13, 15] . A higher proportion of the biologically less active PLC cannot, therefore, account for the insulin resistance seen in these patients.
Though the range of values is wide, it is clear that the highest percent PLC is seen in patients with benign or malignant insulin secreting tumors [12--16] . In our original study, in a single diabetic subject with severe glucose intolerance and relative hypoinsulinemia, we found that the PLC, in multiple samples, comprised from one-third to one-half of the total IRI [3] . It has also been shown that patients with hypokalemia and low total insulin concentrations, have a higher proportion of the PLC than is found in either normal or hyperinsulinemie subjects [17] .
We now present further evidence that most hypoinsulinemic states, regardless of etiology, are characterized by a higher percentage of the PLC and suggest that in these patients, as well as in patients with an insulinoma, the competence of the secretory granule of the B-cell to store insulin may be the primary factor that determines the proportion of the plasma PLC in disease states in man.
Materials and Methods
Five non-obese male patients with diabetes mellitus were studied as inpatients on a metabolic unit. Four of the five ranged in age from 45--55 years and one patient (RAM) was 68 years of age. One non-obese 50 year:old female patient with both biochemical and histologic evidence of pheochromoeytoma was studied before and after surgical removal of the tumor. All six patients had normal renal function as assessed by blood urea nitrogen (BUN) and serum creatinine, and all had normal serum electrolytes and liver function, as determined by standard laboratory procedures.
Each patient consumed a diet that contained at least 300 g of carbohydrate for at least three days prior to a 100 g oral glucose tolerance test, which was performed in the morning after an overnight fast. None of the patients had received insulin therapy prior to the test, but all became insulin requiring shortly after these studies.
Blood glucose and total plasma IRI were determined as previously described [3, 12] . The plasma insulin components were separated by gel filtration. 7 ml of plasma or less (the concentration of total II~I determined the volume of plasma required) were applied to a 1.5 • 90 cm column of G-50 Sephadex (fine) and eluted ~dth 0.05 N[ (NH4)2CO 3, pit 8.6, as previously described [12, 18] . The resultant fractions were lyophilized to dryness, dissolved in the diluent for the radioimmunoassay and the concentration of II~I determined. All results are expressed in terms of a porcine insulin standard and can be compared only to other workers using porcine or human insulin standards and gel filtration separation.
Results
All five diabetic patients had a marked elevation of the fasting blood glucose (range 170--320 mg/100 ml) and demonstrated severe glucose intolerance (peak glucose 350 mg/100 ml--500 rag/100 ml) during a 100 g oral glucose tolerance test. All five patients exhibited a severely impoverished insulin response, with three of the patients showing less than a 25 ~U/ml peak value and the other two exhibiting no greater than a 50 ~U/ml response, in the presence of very high concentrations of blood glucose (Figs. 1 and 2).
When plasma was filtered over G-50 Sephadex, two discrete immunoreactive components were seen (Figs. 1 and 2). The less retarded component represented the PLC while the lower molecular weight immunoreactive component represented the insulinlike component. The highest proportion of the PLC was seen in the basal state as has previously been reported for all other conditions [12] . There was little change in the concentration of the PLC at 15 min after oral glucose and only a small change in the percent PLC, commensurate with the lack of significant change in total insulin concentration. By two hours after oral glucose there was a rise in the concentration of the PLC, and a return of the percent PLC to values similar to those seen in the basal state (Fig. 2) .
Patients with pheochromocytoma may have glucose intolerance associated with hypoinsulinemia [19, 20] . Our patient with pheochromocytoma demonstrated marked fasting hyperglycemia, severe glucose intolerance, and a very low total insulin response. When plasma was fraotionated, proportions of the PLC were similar to the hypoinsulinemie diabetic subjects. When the pheochromoeytoma was surgically removed, all clinical signs of the disease disappeared including the glucose and insulin abnormalities. By one year after removal of the tumor the fasting blood glucose had returned to normal, glucose tolerance was near normal (glucose at 2 hrs after oral glucose ----150 rag/100 ml) and the total insulin response was appropriate for the glucose values (Fig. 3) . Nor- (Top) Glucose and total insulin responses. Note there was little change in the total insulin concentration with severe hyperglycemia or with intravenously administered tolbutamide in the presence of hyperglycemia. (Insulin concentration in ng/ml• 25 = ~U/ml.) (Bottom) G-50 Sephadex gel filtration pattern of plasma drawn at 120 rain. 250 ml of heparinized plasma were prefiltered on a 8X 100 cm column and the fractions comprising the proinsulin-like (PLC) and insulin-like component (Insulin) were separately pooled, concentrated and individually filtered on a 1.5 • 90 cm G-50 (free) Sephadex column [12, 18] . The filtration pattern for each component between markers of i25I-albumin (~) left and i~sI (~) right are shown. The total I1~I concentration from each fraction (vertical axis) is plotted as a function of the elution volume of the fraction. When these partially purified fractions were separately pooled and subjected to further gel filtration, [5] immunochemical dilution, [5] and radioreceptor assay [21--23] they were indistinguishable from similar preparatior~s obtained from normaI or hyperinsulinemic patients realization of the glucose and total insulin concentration resulted in a fall in the percent PLC in the basal state and at 15 rain after oral glucose, but there was no change 120 min after oral glucose. The lack of change in the percent PLC 120 rain after oral glucose is commensurate with the almost identical total insulin concentrations at this time in both the pre-and postoperative samples.
Patient Lij
insulinemie responses, and are comparable to values seen in insulinopenic patients with hypokalemia (Fig. 4) . The low total IRI response in these patients results from a lower concentration of the PLC as well as the insulin component, compared to normal or hyperinsulinemie patients, but the relative proportion of the total Ii~I comprising the PLC is greater in the hypoinsulinemie patients. The mean percent of PLC for the four diabetic patients (patient Lij (Fig. 1 ) not included because he was studied at only a single time point) and the one patient with a pheoehromocytoma are as follows: in the basal state, 37% (range 30--50%); 15 rain after oral glucose, 27% (range 20--32%); and at 120 min, 32O/o (range 23--50%). These values are distinctly higher than those seen in normal subjects or in patients with glucose intolerance and hyperTo determine whether the PLC from a patient with severe hypoinsnlinemia had similar properties to material obtained from normal subjects or hyperinsulinemie patients, the individual components were isolated from a large volume of plasma (Fig. 1) . The partially purified, proinsulin-like and insulin-like components in this severely hypoinsulinemie patient were found to have the same gel filtration [5] , iramunochemieal [5] 
Discussion
We have found that patients with clinical conditionb characterized by glucose intolerance associated with hypoinsulinemia have a higher proportion of their total IRI in the proinsulin-like form. This includes the patient in our initial report whose "big" PLC, commensurate with their very small change in total insulin response [24] . This suggested that potassium deficiency per se was not the major factor and that the common denominator between the hypokalemie patients and the patients in this report is hypoinsulinemia. Thus, it is patients with insulinoma and patients with hypoinsulinemia who have the highest percent PLC.
Before attempting to relate the concentration or proportion of a hormone to an event involving secretion, the metabolism of that hormone must be care- insulin comprised up to 50% of total IgI, a patient who, in fact, had severe glucose intolerance with hypoinsulinemia [3] . These values are lower than are seen in many patients with an insulinoma, but are greater than those usually seen in normal subjects or in hyperinsulinemic patients. Furthermore, the increased percent PLC can be decreased in individual patients when their impoverished insulin secretion is improved [17] . Following our demonstration that hypokalemie patients with decreased total insulin responses had a relatively high proportion of the PLC, we attempted to reproduce this phenomenon in normal subjects by ex~perimental potassium depletion. The normal subjects, though significantly potassium depleted and hypokalemie, had essentially no change in their percent fully considered. The major sites of degradation of proinsulin and insulin are different, proinsulin being degraded primarily by the kidney and insulin mainly by the liver [25, 26] . This is compatible with a higher percentage of the PLC in patients with renal disease than in patients with hepatic disease [27] . Furthermore, exogenously administered insulin disappears faster from the plasma of animals [26, 28] and man [29] than does exogenously administered proinsulin, and endogenous insulin disappears faster than the endogenous PLC from the plasma of patients undergoing removal of islet cell adenomas [6, 30] . The slower degradation rate of the plasma PLC accounts in part for the fact that the percent PLC may be 4--5 times greater in plasma than in the pancreas. While the peripheral metabolism of proinsulin and insulin is different, there is no evidence that the metabolism of the PLC per se is altered in any disease state other than uremia. The metabolism of insulin is unaltered over the physiologic range of insulin concentration [25] and it seems reasonable to speculate that the same is true for proinsulin. Since the connecting peptides of animal proinsulins are very different from human proinsulin, definitive proof of this point in man must await sufficient supplies of human proinsulin.
Proinsulin is synthesized on the ribosome of the B-cell and then transferred to the Golgi region, where the events in secretory granule formation begin [31, 32] . As the immature fl-granule goes through the incubation medium as is found in plasma ; this amount is several fold greater than the percent PLC in the tumor [12] . In a detailed and systematic study Creutzfeldt and associates have found that the proportion of proinsulin found in insulinomas is proportional to the relative number of beta granules and that degranulation is greatest in malignant insulinomas [33] . In addition, these workers have demonstrated an increase in the turnover rate of both proinsulin and insulin in human insulinoma tissue as compared to normal pancreatic islets [34] . Furthermore, patients with malignant insulinomas tend to have the highest proportions of the PLC in plasma [16] . These data, taken together, suggest that diseases that affect the [12, 17] are eompared to the hypoinsulinemie patients described in this report (A) process of maturation, proinsulin is converted to insulin. Thus, the immature secretory granule is relatively rich in proinsulin. The integrity of the flgranule is, therefore, essential for the normal process of storage and secretion of insulin. In the normal rat islet, in vitro, this proceeds in an orderly fashion and insulin is predominantly secreted into the incubation medium [32] . Only small amounts of proinsulin appear in the media after about two hours of incubation and there is no apparent preferential secretion of proinsulin. The events that characterize insulin and proinsulin secretion from the normal islet may not completely apply to the pathologic islet. A high percentage of the PLC is seen in the plasma of golden hamsters who harbor transplantable islet cell tumors. Furthermore, when slices of these tumors are incubated in vitro a similar proportion of the PLC appears in the beta cell's ability to store and to secrete insulin or prevent the beta granule from undergoing full maturation will be associated with an increased secretion from immature granules, which contain a higher percent of proinsulin. This does not exclude the possibility that islet cell tumors may also synthesize proinsulin at an increased rate, or that under some circumstances nongranular secretion may occur.
Thus, in hypoinsulinemie patients, with a constant stimulus to the B-cell to secrete insulin, the proportion that will be secreted in the pro-insulia form will depend upon the relative number of granules and the functional integrity of the secretory apparatus. A similar set of circumstances might occur in patients with insulinoma even though insulin secretion may occur spontaneously. Finally, our data suggest that the increased proportion of the PLC seen in hypoinsulinemic patients is a reflection of the defect in the B-cell to store and secrete insulin rather than of a specific disease process that leads to this defect.
